Medication or psychotherapy effective in treating depressed patients when the other is not

May 02, 2005

CHICAGO - Switching from an antidepressant medication to psychotherapy or vice versa may improve symptoms in chronically depressed patients who prove unresponsive to their initial treatment, according to an article in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

"A substantial proportion of patients treated for depression do not respond to the initial trial of either an antidepressant medication or depression-targeted psychotherapy," according to background information in the article. For those resistant to treatment there are several options available, including switching medication, enhancing or combining medications, and switching to or enhancing treatment with psychotherapy.

Alan F. Schatzberg, M.D., from Stanford University School of Medicine, Stanford, Calif., and colleagues studied chronically depressed patients who were treated with either nefazodone (an antidepressant medication) or cognitive behavioral analysis system of psychotherapy (CBASP) for 12 weeks. Participants in the nefazodone group received an initial does of 200 mg per day (100 mg twice daily), which increased to a maximum of 600 mg per day. Those in the CBASP group attended sessions twice weekly during the first four weeks and then once weekly until week 12. If unresponsive to either the nefazodone or CBASP, patients were switched to the other treatment.

Of the 156 nonresponders, 140 (89.7 percent) agreed to the crossover therapy. Both the switch from nefazodone to CBASP, and CBASP to nefazodone resulted in an improvement of depression symptoms. The response rates were 57 percent for those who crossed over from nefazodone to CBASP, and 42 percent for those who switched from CBASP to nefazodone. Remission rates were not significantly different in the two groups.

"Among chronically depressed individuals, CBASP appears to be efficacious for nonresponders to nefazodone, and nefazodone appears to be effective for CBASP nonresponders," the authors write. "For patients with chronic depression, the present results provide a strong basis for switching to CBASP after a medication does not produce a response and, conversely, for switching to medication after patients do not respond to an adequate trial of psychotherapy."
-end-
(Arch Gen Psychiatry. 2005; 62: 513 - 520. Available post-embargo at www.archgenpsychiatry.com.)

Editor's Note: This multicenter project was supported in part by a series of grants from Bristol-Myers Squibb Co., New York.

The JAMA Network Journals

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.